about
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursorsA nested case-control study of intrauterine exposure to persistent organochlorine pollutants and the risk of hypospadiasFour year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trialChapter 28: Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries.Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries.Cutaneous human papillomavirus 88: remarkable differences in viral load.High-throughput genotyping of oncogenic human papilloma viruses with MALDI-TOF mass spectrometry.Multiplex detection of human herpesviruses from archival specimens by using matrix-assisted laser desorption ionization-time of flight mass spectrometry.Cohort Profile: The Janus Serum Bank Cohort in Norway.Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples.Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasiaH. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship?Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.Prospective study of human papillomavirus and risk of cervical adenocarcinomaRisk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervixRandomised health services studies.Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.Interactive effect of genetic susceptibility with height, body mass index, and hormone replacement therapy on the risk of breast cancer.A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types.Genetic predisposition, parity, age at first childbirth and risk for breast cancer.Global proficiency study of human papillomavirus genotyping.Evaluation of antibodies to human papillomavirus as prognostic markers in cervical cancer patients.Human papillomavirus and Papanicolaou tests to screen for cervical cancer.Unbiased approach for virus detection in skin lesions.Patterns of human papillomavirus types in multiple infections: an analysis in women and men of the high throughput human papillomavirus monitoring study.Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.Translational cancer research: balancing prevention and treatment to combat cancer globally.Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasiaMinor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.Can genital-tract human papillomavirus infection and cervical cancer be prevented with a vaccine?Screening and cervical cancer cure: population based cohort study.Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.Human papillomavirus antibody reference reagents for use in postvaccination surveillance serology.Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC CohortPerformance of commercial reverse line blot assays for human papillomavirus genotyping.In vivo and in vitro intragenomic rearrangement of TT viruses.Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control StudyThe 2010 global proficiency study of human papillomavirus genotyping in vaccinology.
P50
Q24235373-F21383B3-4F48-4290-9941-97050B1DA73AQ28484089-30539D12-41BE-42F0-A663-D544B0F25945Q28750269-9FEAB70C-BA27-416F-BC76-85E67CF14E69Q30230410-715362BD-E4C9-4671-BF9B-E34F87F40470Q31113615-937E1DF7-5AE1-4D34-AC4E-09F88A15513DQ31133016-FF2806F1-289B-4496-B7E0-EFDCF2ADDC34Q33304957-878B5773-F71B-40CF-81B9-D1AC729A539EQ33311453-CA50F557-DBB9-4CFD-A773-124C724830B6Q33458121-F21EAA42-2CCB-40A8-A624-57A57613B40AQ33517490-5CA272A9-34E0-45A5-886E-B65B8112D8D7Q33740343-BA325054-1DA9-4273-851F-AAAF2F4B305CQ33844717-AE4D3B45-FABF-44A9-A969-D35723998D2DQ33885141-7E70BC59-BDD2-4A1C-BD1B-B690DBFBBF49Q34091747-BA71A329-D707-41DC-BC96-91C502019EE2Q34147515-09CDD7C5-DFAF-4C8C-9E50-F140E120A10EQ34187128-F21624FF-3753-46CC-B083-7688AD56388DQ34264588-31898FE1-E7C7-42CF-A17C-8110D4F4642EQ34299355-BE1AECA7-B13D-418D-8B89-8F82500F1D7BQ34314805-BAA1F898-D92E-45A2-875D-D6419B1DFFCCQ34362772-4A1CE752-25BC-4E4F-A25E-2CAFE7A23D08Q34367710-181C7D64-03E9-4E52-A5A3-AB6DBAAF5973Q34489632-F4C4CF24-E6B3-45FD-8DA5-C4DC24213C18Q34612005-9A14D24A-D8BC-4A2D-8FA8-E58A1377CB02Q34702284-2BF6BBA6-4408-4BD3-83FC-48B3444BF244Q34804828-85287E1F-2419-44FC-A63E-4A02FC0A5A56Q34971664-952DAFF0-EEAE-4DF6-9331-89B37FE05995Q35088687-68148A5E-2E69-42D2-B791-A2181E6FA9A5Q35102711-24883B58-F077-41F5-96D9-72A85D916D97Q35656638-F262C0FF-9E28-4E8A-B2A6-CF9525976A09Q35665790-1716CB14-F3C8-47C0-BEA6-C32B91B79B26Q35750770-5E04321D-EDDD-4E36-9BD3-1FC3A0D839DDQ35794911-956E0559-6EC6-45AE-B375-495F92FEE163Q35802505-6AE6FA03-3DA9-413B-BA63-0D39A7426E33Q35805297-C28A9CF0-D8B6-41DC-B9F4-6FD645E33982Q35901974-7EED1B2F-6227-42BF-AB5D-BC56D3DEC9C0Q35903393-29EE5FD6-C167-47E1-BBBD-CB9688674527Q35942878-7B7E1568-9B93-4CE1-907B-4A359BA8BC11Q35948002-121D065F-4EA6-498A-B7FB-E4B88823AB02Q36030050-8A08D4B3-2C54-459E-A5B9-E5C943F959C3Q36118729-DE9A61EC-EAE9-42BE-AC6F-F5125BB824B1
P50
description
Zweeds onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joakim Dillner
@ast
Joakim Dillner
@en
Joakim Dillner
@es
Joakim Dillner
@nl
Joakim Dillner
@sl
type
label
Joakim Dillner
@ast
Joakim Dillner
@en
Joakim Dillner
@es
Joakim Dillner
@nl
Joakim Dillner
@sl
prefLabel
Joakim Dillner
@ast
Joakim Dillner
@en
Joakim Dillner
@es
Joakim Dillner
@nl
Joakim Dillner
@sl
P106
P21
P27
P31
P496
0000-0001-8588-6506